Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Floxin Otic launched in U.S.

Feb. 24, 1998

Clinical status of CS-834

Feb. 23, 1998

Idec RSV antibodies covered by U.S. patents; development partners sought

Feb. 23, 1998

Rifaximin receives orphan drug status in hepatic encephalopathy

Feb. 23, 1998

SKB evaluates RF-1 as antibacterial target

Feb. 23, 1998

Advisory panel recommends approval of Synercid

Feb. 20, 1998

Glaxo Wellcome enrolls patients in phase III flu drug trials

Feb. 20, 1998

Shionogi investigates new cephem compounds

Feb. 19, 1998

KY-62 evaluated in murine models of candidiasis

Feb. 18, 1998

Cubist outlines development plans for daptomycin

Feb. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...